Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$49.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Abiomed Inc


Wednesday, 21 Nov 2012 06:30pm EST 

Glancy Binkow & Goldberg LLP, representing investors of Abiomed Inc, announced that it has filed a class action lawsuit in the United States District Court for the District of Massachusetts on behalf of a class (the Class) consisting of all purchasers of Abiomed securities between August 5, 2011 and October 31, 2012, inclusive (the Class Period). The Complaint alleges that throughout the Class Period the defendants made materially false and misleading statements regarding the Company’s business, operations and financial prospects. Specifically, defendants misrepresented and/or failed to disclose that: (1) the Company was improperly marketing and/or labeling its Impella 2.5 system; (2) the Company’s financial results would be materially impacted if the Company were either forced to stop its improper conduct or unable to continue its improper conduct; (3) the Company lacked adequate internal and financial controls; and (4) as a result of the foregoing, the Company’s statements were materially false and misleading at all relevant times. 

Company Quote

26.29
0.04 +0.15%
25 Jul 2014